Physician profile
Marek Kurowski
NPI 1366685653
$6,346.77
in general payments reported to CMS, 2019-2025
18 companies · $1,989 in 2025
The $1,989 reported for 2025 was more than what 78% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,614 · 2022: $49.58 · 2023: $581 · 2024: $1,113 · 2025: $1,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,244 · Travel and Lodging: $1,439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,244.34 |
| Travel and Lodging | $1,438.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,721.06 | 2019 | |
| Si-Bone, INC. | $1,064.53 | 2019-2025 | |
| Curonix LLC | $596.43 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $582.30 | 2019 | |
| Vertos Medical, INC. | $439.95 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $430.48 | 2023-2025 | Sprint Pns System |
| Surgentec | $232.26 | 2023 | Tilink, Ion Facet Screw System |
| Foundation Fusion Solutions, LLC | $197.67 | 2023-2024 | |
| Mml US, INC. | $164.11 | 2023 | Reactiv8 |
| Medtronic, INC. | $161.13 | 2025 | Intellis Adaptivestim, Inceptiv |
| Avanos Medical | $151.76 | 2019 | |
| Boston Scientific Corporation | $149.26 | 2024 | |
| Abbott Laboratories | $140.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $123.48 | 2025 | Wainua |
| Stryker Corporation | $78.64 | 2023-2024 | Spinejack, Optablate, Multigen 2 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $50.00 | 2025 | |
| Grt US Holding, INC. | $49.58 | 2022 | |
| Nalu Medical, INC. | $13.75 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marek Kurowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.